Authors: Jehle, PM Jehle, DR

Citation: Pm. Jehle et Dr. Jehle, Use of corticosteroids in nephrology - risk and prevention of osteoporosisinduction, NEPH DIAL T, 15(5), 2000, pp. 565-568

Authors: Ebinger, M Jehle, DR Fussgaenger, RD Fehmann, HC Jehle, PM

Citation: M. Ebinger et al., Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes, AM J P-ENDO, 279(1), 2000, pp. E88-E94

Authors: Jehle, PM Ostertag, A Schulten, K Schulz, W Jehle, DR Stracke, S Fiedler, R Deuber, HJ Keller, F Boehm, BO Baylink, DJ Mohan, S

Citation: Pm. Jehle et al., Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy, KIDNEY INT, 57(2), 2000, pp. 423-436

Authors: Jehle, PM Micheler, C Jehle, DR Breitig, D Boehm, BB

Citation: Pm. Jehle et al., Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens, LANCET, 354(9190), 1999, pp. 1604-1607

Authors: Jehle, DR Keller, F Schwarz, A Jehle, PM

Citation: Dr. Jehle et al., Hypercalcemia-induced renal insufficiency during therapy with dihydrotachysterol, J MED, 30(1-2), 1999, pp. 39-50